We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Flavonoids Kill Human Pancreatic Cancer Cells

By LabMedica International staff writers
Posted on 26 Aug 2013
Print article
Flavonoids in celery, artichokes, and especially Mexican oregano contain flavonoids that kill human pancreatic cancer cells by enzymatic inhibition, according to a new study.

Two researchers at the University of Illinois (UIC; Chicago, IL, USA) examined the inhibitory effects of flavonoids, limonoids, phenolic acids, and ascorbic acid citrus fruit bioactive compounds on BxPC-3 and PANC-1 human pancreatic cancer cells in vitro, focusing on the antiproliferative mechanism of action of the flavonoid apigenin as related to the glycogen synthase kinase-3β (GSK-3β) nuclear factor kappa B signaling pathway.

The researchers found that apigenin inhibited the GSK-3β enzymatic pathway, leading to a decrease in the production of antiapoptotic genes in the pancreatic cancer cells, thus encouraging the cancer cells to self-destruct via apoptosis. In one of the cancer cell lines, the percentage of cells undergoing apoptosis went from 8.4% in cells that had not been treated with the flavonoid to 43.8% in cells that had been treated with a 50-micromolar dose. Treatment with the flavonoid also modified gene expression, causing upregulation of certain genes associated with pro-inflammatory cytokines such interleukin 17. The study was published on August 13, 2013, in Molecular Nutrition and Food Research.

“Apigenin alone induced cell death in two aggressive human pancreatic cancer cell lines. But we received the best results when we pretreated cancer cells with apigenin for 24 hours, then applied the chemotherapeutic drug gemcitabine for 36 hours,” said study coauthor professor Elvira de Mejia, PhD. “Pancreatic cancer patients would probably not be able to eat enough flavonoid-rich foods to raise blood plasma levels of the flavonoid to an effective level. But scientists could design drugs that would achieve those concentrations.”

“The trick seemed to be using the flavonoids as a pretreatment instead of applying them and the chemotherapeutic drug simultaneously. Even though the topic is still controversial, our study indicated that taking antioxidant supplements on the same day as chemotherapeutic drugs may negate the effect of those drugs,” added coauthor Jodee Johnson, PhD. “That happens because flavonoids can act as antioxidants. One of the ways that chemotherapeutic drugs kill cells is based on their pro-oxidant activity, meaning that flavonoids and chemotherapeutic drugs may compete with each other when they're introduced at the same time.”

Flavonoids are a class of plant secondary metabolites that may modify allergens, viruses, and carcinogens, and demonstrate significant antioxidant activity in vitro that may be stronger than those of vitamin C and E. However, inside the human body, they have little or no direct antioxidant value, since flavonoids are poorly absorbed (less than 5%), with most of what is absorbed being quickly metabolized and excreted.

Related Links:

University of Illinois



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.